News
|
Careers
|
Contact Us
About Vanda
Development Pipeline
24
Discovery Research
Investor Relations
meet vanda
We are using pharmacogenetics to match promising molecules
to the right patients. So selecting the right medicine will be
easier, thanks to our more personal approach.
May 08, 2012
Vanda Pharmaceuticals Reports First Quarter 2012 Results
Apr 18, 2012
Vanda Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 8, 2012
Apr 16, 2012
Vanda Pharmaceuticals Acquires Rights to NK-1 Receptor Antagonist from Eli Lilly and Company
Read More in the Newsroom
Fanapt™(iloperidone)
Tasimelteon